Chemotherapy and treatment algorithms for follicular lymphoma: a look at all options

摘要: The outcome of patients with follicular lymphoma has substantially improved in recent years, mainly due to the widespread use monoclonal antibody rituximab and partially autologous allogeneic transplantation, introduction new drugs improvement diagnostic accuracy. choice therapy is still based on patient characteristics, extension disease clinical prognostic factors. majority need treatment are treated cytotoxic agents combination rituximab; nevertheless a number agents, which active this disease, have recently been developed. It yet be determined, whether they will partly or completely replace chemotherapy near future. This review focuses role different situations lymphoma, time when chemotherapy-free becomes more topic discussion.